Business Context and Reporting Period
Company: Lexicon Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 23, 2025
Reporting Period: Specific event date of July 23, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report addresses a regulatory compliance event rather than financial performance.
Material Changes
Regulatory Status: The company received notification from the Listing Qualifications staff of The NASDAQ Stock Market LLC on July 23, 2025, confirming it has regained compliance with the minimum $1 bid price requirement for its common stock. The matter regarding the previous failure to meet this requirement is now closed.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or discussion of future risks. The primary focus is the resolution of the prior listing deficiency.
Investor Verification Checklist
- Verify the current trading price of LXRX on The Nasdaq Global Select Market to confirm sustained compliance with the $1 minimum bid price.
- Review the company's recent financial statements to understand the capital position supporting the stock price recovery.
- Monitor for any future correspondence from Nasdaq regarding other listing standards (e.g., market value of listed securities or shareholder equity).